Heterogeneity of Heparan Sulfates in Human Lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 2, 2004, Pages 166-173

  Smits, Nicole C ^b   Robbesom, Antoine A ^b   Versteeg, Elly M M ^b   Van De Westerlo, Els M A ^b   Dekhuijzen, P N Richard ^b   Van Kuppevelt, Toin H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; EPITOPE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARAN SULFATE ANTIBODY; HEPARIN; POLYANION; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; BASEMENT MEMBRANE; BINDING SITE; CARBOHYDRATE ANALYSIS; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; MACROPHAGE; MALE; PHAGE DISPLAY; STAINING; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES; EPITOPES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HEPARITIN SULFATE; HUMANS; LUNG; MACROPHAGES; MALE; MIDDLE AGED; PEPTIDE LIBRARY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0742307394     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0198OC     Document Type: Article

References (40)

1. Stringer, S. E., and J. T. Gallagher. 1997. Heparan sulphate. Int. J. Biochem. Cell Biol. 29:709-714.
2. Lindahl, U., M. Kusche-Gullberg, and L. Kjellen. 1998. Regulated diversity of heparan sulfate. J. Biol. Chem. 273:24979-24982.
3. Lindahl, U. 1994. The great Scandinavian Jahre Prize 1993: what is the function of heparan sulfate? Nord. Med. 109:4-8.
4. Bernfield, M., M. Gotte, P. W. Park, O. Reizes, M. L. Fitzgerald, J. Lincecum, and M. Zako. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68:729-777.
5. Gallagher, J. T. 2001. Heparan sulfate: growth control with a restricted sequence menu. J. Clin. Invest. 108:357-361.
6. Li, D., C. C. Clark, and J. C. Myers. 2000. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J. Biol. Chem. 275:22339-22347.
7. van Kuppevelt, T. H., F. P. Cremers, J. G. Domen, H. M. van Beuningen, A. J. van den Brule, and C. M. Kuyper. 1985. Ultrastructural localization and characterization of proteoglycans in human lung alveoli. Eur. J. Cell Biol. 36:74-80.
8. Wang, Y., K. Sakamoto, J. Khosla, and P. L. Sannes. 2002. Detection of chondroitin sulfates and decorin in developing fetal and neonatal rat lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L484-L490.
9. Ringvall, M., J. Ledin, K. Holmborn, T. van Kuppevelt, F. Ellin, I. Eriksson, A. M. Olofsson, L. Kjellen, and E. Forsberg. 2000. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N- sulfotransferase-1. J. Biol. Chem. 275:25926-25930.
10. Fan, G., L. Xiao, L. Cheng, X. Wang, B. Sun, and G. Hu. 2000. Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett. 467:7-11.
11. Sannes, P. L., J. Khosla, and P. W. Cheng. 1996. Sulfation of extracellular matrices modifies responses of alveolar type II cells to fibroblast growth factors. Am. J. Physiol. 271:L688-L697.
12. van Kuppevelt, T. H., F. P. Cremers, J. G. Domen, and C. M. Kuyper. 1984. Staining of proteoglycans in mouse lung alveoli: II. Characterization of the Cuprolinic blue-positive, anionic sites. Histochem. J. 16:671-686.
13. Sannes, P. L. 1984. Differences in basement membrane-associated microdomains of type I and type II pneumocytes in the rat and rabbit lung. J. Histochem. Cytochem. 32:827-833.
14. Li, Q., P. W. Park, C. L. Wilson, and W. C. Parks. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635-646.
15. Dennissen, M. A., G. J. Jenniskens, M. Pieffers, E. M. Versteeg, M. Petitou, J. H. Veerkamp, and T. H. van Kuppevelt. 2002. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J. Biol. Chem. 277:10982-10986.
16. Jenniskens, G. J., A. Oosterhof, R. Brandwijk, J. H. Veerkamp, and T. H. van Kuppevelt. 2000. Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J. Neurosci. 20:4099-4111.
17. Winter, G., and C. Milstein. 1991. Man-made antibodies. Nature 349:293-299.
18. van de Lest, C. H., E. M. Versteeg, J. H. Veerkamp, and T. H. van Kuppevelt. 1994. Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal. Biochem. 221:356-361.
19. Pieper, J. S., T. Hafmans, P. B. van Wachem, M. J. van Luyn, L. A. Brouwer, J. H. Veerkamp, and T. H. van Kuppevelt. 2002. Loading of collagen, heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J. Biomed. Mater. Res. 62:185-194.
20. Cardin, A. D., and H. J. Weintraub. 1989. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21-32.
21. Ernst, S., R. Langer, C. L. Cooney, and R. Sasisekharan. 1995. Enzymatic degradation of glycosaminoglycans. Crit. Rev. Biochem. Mol. Biol. 30: 387-444.
22. Linker, A., and P. Hovingh. 1973. The heparitin sulfates (heparan sulfates). Carbohydr. Res. 29:41-62.
23. Radhakrishnamurthy, B., N. E. Jeansonne, and G. S. Berenson. 1984. Heterogeneity of heparan sulfate chains in a proteoglycan from bovine lung. Biochim. Biophys. Acta 802:314-320.
24. Linker, A., and P. Hovingh. 1975. Structural studies of heparitin sulfates. Biochim. Biophys. Acta 385:324-333.
25. Salmivirta, M., K. Lidholt, and U. Lindahl. 1996. Heparan sulfate: a piece of information. FASEB J. 10:1270-1279.
26. Jenniskens, G. J., M. Ringvall, W. J. Koopman, J. Ledin, L. Kjellen, P. H. Willems, E. Forsberg, J. H. Veerkamp, and T. H. Van Kuppevelt. 2003. Disturbed Ca2+ kinetics in N-deacetylase/N-sulfotransferase-1 defective myotubes. J. Cell Sci. 116:2187-2193.
27. Ali, S., L. A. Hardy, and J. A. Kirby. 2003. Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans? Transplantation 75:1773-1782.
28. Frevert, C. W., M. G. Kinsella, C. Vathanaprida, R. B. Goodman, D. G. Baskin, A. Proudfoot, T. N. Wells, T. N. Wight, and T. R. Martin. 2003. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am. J. Respir. Cell Mol. Biol. 28:464-472.
29. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:471-501.
30. Henke, C., W. Marineili, J. Jessurun, J. Fox, D. Harms, M. Peterson, L. Chiang, and P. Doran. 1993. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am. J. Pathol. 143:1189-1199.
31. Tuder, R. M., I. Petrache, J. A. Elias, N. F. Voelkel, and P. M. Henson. 2003. Apoptosis and emphysema: the missing link. Am. J. Respir. Cell Mol. Biol. 28:551-554.
32. Kasahara, Y., R. M. Tuder, C. D. Cool, D. A. Lynch, S. C. Flores, and N. F. Voelkel. 2001. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 163:737-744.
33. Kasahara, Y., R. M. Tuder, L. Taraseviciene-Stewart, T. D. Le Cras, S. Abman, P. K. Hirth, J. Waltenberger, and N. F. Voelkel. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106:1311-1319.
34. Kanazawa, H., K. Asai, K. Hirata, and J. Yoshikawa. 2003. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am. J. Med. 114:354-358.
35. Walsh, R. L., T. J. Dillon, R. Scicchitano, and G. McLennan. 1991. Heparin and heparan sulphate are inhibitors of human leucocyte elastase. Clin. Sci. (Lond.) 81:341-346.
36. Rao, N. V., T. P. Kennedy, G. Rao, N. Ky, and J. R. Hoidal. 1990. Sulfated polysaccharides prevent human leukocyte elastase-induced acute lung injury and emphysema in hamsters. Am. Rev. Respir. Dis. 142:407-412.
37. Brown, G. M., D. M. Brown, and K. Donaldson. 1991. Inflammatory response to particles in the rat lung: secretion of acid and neutral proteinases by bronchoalveolar leucocytes. Ann. Occup. Hyg. 35:389-396.
38. van de Lest, C. H., E. M. Versteeg, J. H. Veerkamp, J. H. Berden, J. van den Born, L. Heunks, J. W. Lammers, C. L. van Herwaarden, P. N. Dekhuijzen, and T. H. van Kuppevelt. 1996. Altered composition of urinary heparan sulfate in patients with COPD. Am. J. Respir. Crit. Care Med. 154:952-958.
39. van den Born, J., K. Gunnarsson, M. A. Bakker, L. Kjellen, M. Kusche-Gullberg, M. Maccarana, J. H. Berden, and U. Lindahl. 1995. Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J. Biol. Chem. 270:31303-31309.
40. Tomlinson, I. M., G. Walter, J. D. Marks, M. B. Llewelyn, and G. Winter. 1992. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J. Mol. Biol. 227:776-798.